RESOURCES

Cardiovascular disease - identification and treatment of people at high risk
Cardiovascular disease - identification and treatment of people at high risk

An update on primary prevention of cardiovascular disease (CVD). In this article, we focus on risk factor management for people with established CVD, with the aim of preventing further cardiovascular events.

Heart Valve Disease – A guide for patients
Heart Valve Disease – A guide for patients

The British Heart Valve Society (BHVS) has produced a book for patients, all about heart valve disease. It is available for purchase through the BHVS website: https://www.bhvs.org.uk/book/

It was written with patients in mind and with heavy input from patients. Initial feedback has been really positive. It has been beautifully illustrated by a professional graphic designer.

Detecting AF in COVID-19 vaccine centres – helping to reduce the number of AF-related strokes
Detecting AF in COVID-19 vaccine centres – helping to reduce the number of AF-related strokes

As we are all aware, due to the COVID-19 pandemic, fewer people have sought help when experiencing symptoms of cardiovascular disease and stroke. Despite TV advertisements and government messaging, we are still seeing an increase in deaths due to heart disease and strokes.

PHE Cardiovascular Disease Prevention Packs
PHE Cardiovascular Disease Prevention Packs

Public Health England has just published the latest iteration of their CVD prevention packs which provide STP/CCG/Practice level data around all aspects of cardiovascular disease prevention. 

Primary Care - Heart Failure Diagnostic and Treatment Pathways
Primary Care - Heart Failure Diagnostic and Treatment Pathways
Heart Failure: A Blueprint For Change Executive Summary
Heart Failure: A Blueprint For Change Executive Summary

According to the British Heart Foundation, many people with heart failure are not getting the care they need. This new report sets out a blueprint for how health and care services can better meet patient needs and help people live better for longer.

CaReMe Group Leaflet for people with Diabetes
CaReMe Group Leaflet for people with Diabetes

Cardiology, Renal and Metabolic (CaReMe) group have produced a very helpful leaflet for people with diabetes on SGLT-2 inhibitors.

Pumping Marvellous Foundation and Roche Diagnostics Report - Heart Failure: The Hidden Costs of Late Diagnosis
Pumping Marvellous Foundation and Roche Diagnostics Report - Heart Failure: The Hidden Costs of Late Diagnosis

This new report highlights some major issues surrounding the contemporary diagnosis of heart failure.

Top tips for Heart Failure Specialist Nurses when reviewing patients with Chronic Heart Failure in a virtual consultation
Top tips for Heart Failure Specialist Nurses when reviewing patients with Chronic Heart Failure in a virtual consultation

Use these top tips to assist your virtual consultation with adult patients who have been diagnosed with chronic heart failure with reduced ejection fraction.

Thrombosis UK & PCCS COVID-19 Webinar Series
Thrombosis UK & PCCS COVID-19 Webinar Series

This webinar is a collaboration between Thrombosis UK, Primary Care Cardiovascular Society (PCCS) and will consider: What is the pathway and action for primary care managing acute but not hospitalised thrombosis and patients late presenting with respiratory symptoms?

Top tips for reviewing patients with Chronic Heart Failure in a virtual consultation
Top tips for reviewing patients with Chronic Heart Failure in a virtual consultation

Use these top tips to get the most out of your virtual consultations with your adult patients who have been diagnosed with Chronic Heart Failure with reduced ejection fraction

Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 Diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease)
Guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with Type 2 Diabetes and atherosclerotic cardiovascular disease (coronary artery disease, peripheral arterial disease, cerebrovascular disease)
DVLA fitness to drive guidance
DVLA fitness to drive guidance

Assessing fitness to drive: a guide for medical professionals

Direct Acting Oral Anticoagulants (DOACs) in Renal Impairment: Practice Guide to Dosing Issues
Direct Acting Oral Anticoagulants (DOACs) in Renal Impairment: Practice Guide to Dosing Issues

The purpose of this paper is to explain the background to dosing decisions for DOACs in patients with impaired renal function. The paper focuses on the use of DOACs in patients with atrial fibrillation and provides cases from clinical practice as examples. It is intended as a practice aid, not national guidance, and is particularly suitable for new or less experienced practitioners working in primary care.